HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

AbstractAIM:
to investigate safety and angiographic efficacy of two-stage revascularization with percutaneous coronary intervention (PCI) with stenting delayed by one day in patients with acute myocardial infarction (MI) and massive coronary thrombosis.
MATERIALS AND METHODS:
We included in this study 12 patients with massive infarct related coronary artery thrombus which length was greater than thrice the vessel diameter in the presence of TIMI grade II-III blood flow as detected by coronary angiography (CAG). The emergency PCI was not performed, and conservative antithrombotic therapy continued for 24 hours. After this day, CAG was repeated.
RESULTS:
Repeat CAG in all patients showed thrombus regression which visually appeared as complete lysis in 8, and partial lysis - in 4 patients. Stenting of residual stenosis was performed in 11 patients without complications. In 1 patient residual stenosis was considered insignificant (<50 %) therefore stenting was not performed. No-reflowphenomenon and recurrent MI were not observed.
CONCLUSION:
These data suggest that in patients with massive coronary artery thrombosis conservative antithrombotic therapy for 24 hours followed by repeated CAG and, if required, by stenting of residual stenosis, is safe treatment tactics that might reduce the risk of the no-reflow phenomenon.
AuthorsE V Vyshlov, A L Krylov, A G Syrkina, Y V Alexeeva, S V Demyanov, A E Baev, V A Markov, V V Ryabov
JournalKardiologiia (Kardiologiia) Vol. 59 Issue 2 Pg. 5-9 (Mar 07 2019) ISSN: 0022-9040 [Print] Russia (Federation)
Vernacular TitleTwo-Stage Revascularization in Patients with Acute Myocardial Infarction and Massive Coronary Thrombosis.
PMID30853015 (Publication Type: Journal Article)
Topics
  • Angioplasty, Balloon, Coronary
  • Coronary Angiography
  • Coronary Thrombosis
  • Humans
  • Myocardial Infarction
  • Percutaneous Coronary Intervention
  • Stents
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: